HNGE Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
212.8M
+16.7%
182.3M
+6.8%
170.7M
+10.7%
154.2M
+10.9%
139.1M
Cost of Revenue
28.9M
+2.8%
28.1M
+5.2%
26.7M
-4.7%
28.0M
-32.2%
41.3M
Gross Profit
183.9M
+19.3%
154.2M
+7.1%
144.0M
+14.1%
126.2M
+29.1%
97.8M
Operating Expenses
143.5M
+17.5%
122.2M
+4.6%
116.8M
-11.7%
132.3M
-80.5%
678.4M
R&D
34.1M
+12.3%
30.3M
-7.4%
32.8M
+2.6%
31.9M
-88.6%
280.0M
SG&A
109.5M
+19.2%
91.8M
+9.3%
84.0M
-16.3%
100.4M
-74.8%
398.5M
Operating Income
40.4M
+26.1%
32.1M
+17.7%
27.3M
+547.3%
-6093000
+99.0%
-580671000
EBITDA
41.5M
+24.8%
33.2M
+16.7%
28.5M
+689.7%
-4829000
+99.2%
-579328000
Net Income
43.7M
+24.4%
35.1M
+9.5%
32.1M
+1840.5%
-1844000
+99.7%
-575651000
EPS (Basic)
$0.55
+27.9%
$0.43
+7.5%
$0.40
+2100.0%
$-0.02
+99.8%
$-13.10
EPS (Diluted)
$0.52
+26.8%
$0.41
$-0.02
+99.8%
$-13.10
Shares (Diluted)
83.4M
+1.3%
82.4M
78.9M
+79.5%
43.9M
Hinge Health (HNGE) — Financials